{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:06:13Z","timestamp":1779451573214,"version":"3.53.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":1833,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1074\/jbc.m115.649608","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T20:35:12Z","timestamp":1437424512000},"page":"22049-22060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis"],"prefix":"10.1016","volume":"290","author":[{"given":"Antonia","family":"Sophocleous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mollat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart H.","family":"Ralston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymen I.","family":"Idris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M115.649608_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1054\/plef.2001.0341","article-title":"Cannabinoid receptors and their ligands","volume":"66","author":"Pertwee","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1074\/jbc.M115.649608_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1054\/plef.2001.0342","article-title":"Molecular biology of cannabinoid receptors","volume":"66","author":"Lutz","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1074\/jbc.M115.649608_bib3","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1046\/j.1471-4159.1998.71041525.x","article-title":"Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes","volume":"71","author":"Rhee","year":"1998","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M115.649608_bib4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1042\/bj3120637","article-title":"Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1","volume":"312","author":"Bouaboula","year":"1995","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.M115.649608_bib5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1432-1033.1996.0704p.x","article-title":"Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor: involvement of both mitogen-activated protein kinase and induction of Krox-24 expression","volume":"237","author":"Bouaboula","year":"1996","journal-title":"Eur. J. Biochem"},{"key":"10.1074\/jbc.M115.649608_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0898-6568(03)00036-6","article-title":"Activation of phosphoinositide 3-kinase\/PKB pathway by CB1 and CB2 cannabinoid receptors expressed in prostate PC-3 cells: involvement in Raf-1 stimulation and NGF induction","volume":"15","author":"S\u00e1nchez","year":"2003","journal-title":"Cell Signal"},{"key":"10.1074\/jbc.M115.649608_bib7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/55.3.597","article-title":"Antineoplastic activity of cannabinoids","volume":"55","author":"Munson","year":"1975","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1074\/jbc.M115.649608_bib8","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1038\/onc.2008.145","article-title":"JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells","volume":"27","author":"Caffarel","year":"2008","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M115.649608_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.yexcr.2005.10.024","article-title":"Anandamide inhibits adhesion and migration of breast cancer cells","volume":"312","author":"Grimaldi","year":"2006","journal-title":"Exp. Cell Res"},{"key":"10.1074\/jbc.M115.649608_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jcb.22540","article-title":"Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells","volume":"110","author":"Xian","year":"2010","journal-title":"J. Cell. Biochem"},{"key":"10.1074\/jbc.M115.649608_bib11","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1158\/0008-5472.CAN-03-3720","article-title":"Cannabinoids induce cancer cell proliferation via tumor necrosis factor \u03b1-converting enzyme (TACE\/ADAM17)-mediated transactivation of the epidermal growth factor receptor","volume":"64","author":"Hart","year":"2004","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M115.649608_bib12","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.174.6.3281","article-title":"\u03949-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response","volume":"174","author":"McKallip","year":"2005","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M115.649608_bib13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc1188","article-title":"Cannabinoids: potential anticancer agents","volume":"3","author":"Guzm\u00e1n","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M115.649608_bib14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.bcp.2009.11.007","article-title":"Cannabidiol inhibits cancer cell invasion via up-regulation of tissue inhibitor of matrix metalloproteinases-1","volume":"79","author":"Ramer","year":"2010","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/jbc.M115.649608_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4049\/jimmunol.165.1.373","article-title":"\u03949-Tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway","volume":"165","author":"Zhu","year":"2000","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M115.649608_bib16","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ctrv.2012.06.005","article-title":"Cannabinoids: a new hope for breast cancer therapy?","volume":"38","author":"Caffarel","year":"2012","journal-title":"Cancer Treat. Rev"},{"key":"10.1074\/jbc.M115.649608_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1677\/ERC-07-0258","article-title":"Endocannabinoids in endocrine and related tumours","volume":"15","author":"Bifulco","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1074\/jbc.M115.649608_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1158\/0008-5472.CAN-07-2785","article-title":"Cannabinoids for cancer treatment: progress and promise","volume":"68","author":"Sarfaraz","year":"2008","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M115.649608_bib19","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/mol.114.094649","article-title":"CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?","volume":"86","author":"Dhopeshwarkar","year":"2014","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.M115.649608_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejmech.2012.03.031","article-title":"Rational design, synthesis. and anti-proliferative properties of new CB2-selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold","volume":"52","author":"Manera","year":"2012","journal-title":"Eur. J. Med. Chem"},{"key":"10.1074\/jbc.M115.649608_bib21","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.bjc.6605248","article-title":"Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-methanandamide and JWH-015: involvement of CB2","volume":"101","author":"Olea-Herrero","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1074\/jbc.M115.649608_bib22","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.lfs.2010.02.014","article-title":"A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss","volume":"86","author":"Lozano-Ondoua","year":"2010","journal-title":"Life Sci"},{"key":"10.1074\/jbc.M115.649608_bib23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1476-5381.2009.00629.x","article-title":"Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain","volume":"160","author":"Curto-Reyes","year":"2010","journal-title":"Br. J. Pharmacol"},{"key":"10.1074\/jbc.M115.649608_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jbmr.1732","article-title":"Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists","volume":"28","author":"Lozano-Ondoua","year":"2013","journal-title":"J. Bone Miner. Res"},{"key":"10.1074\/jbc.M115.649608_bib25","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm1255","article-title":"Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors","volume":"11","author":"Idris","year":"2005","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M115.649608_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cmet.2009.07.006","article-title":"Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells","volume":"10","author":"Idris","year":"2009","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.M115.649608_bib27","doi-asserted-by":"crossref","first-page":"16511","DOI":"10.1073\/pnas.0902743106","article-title":"The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo","volume":"106","author":"Whyte","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.649608_bib28","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/mol.106.026435","article-title":"Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling","volume":"70","author":"Tam","year":"2006","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.M115.649608_bib29","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1073\/pnas.0504187103","article-title":"Peripheral cannabinoid receptor, CB2, regulates bone mass","volume":"103","author":"Ofek","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M115.649608_bib30","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1210\/en.2008-0150","article-title":"Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor","volume":"149","author":"Idris","year":"2008","journal-title":"Endocrinology"},{"key":"10.1074\/jbc.M115.649608_bib31","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/en.2010-0930","article-title":"The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation","volume":"152","author":"Sophocleous","year":"2011","journal-title":"Endocrinology"},{"key":"10.1074\/jbc.M115.649608_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00223-013-9793-8","article-title":"Genetic background modifies the effects of type 2 cannabinoid receptor deficiency on bone mass and bone turnover","volume":"94","author":"Sophocleous","year":"2014","journal-title":"Calcif. Tissue Int"},{"key":"10.1074\/jbc.M115.649608_bib33","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1096\/fj.10-164095","article-title":"Small molecule inhibitors of IkappaB kinase signaling inhibit osteoclast formation in vitro and prevent ovariectomy-induced bone loss in vivo","volume":"24","author":"Idris","year":"2010","journal-title":"FASEB J"},{"key":"10.1074\/jbc.M115.649608_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.abb.2008.11.012","article-title":"\u03b22-Adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanisms","volume":"482","author":"Aitken","year":"2009","journal-title":"Arch. Biochem. Biophys"},{"key":"10.1074\/jbc.M115.649608_bib35","series-title":"Bone Research Protocols","first-page":"183","article-title":"Osteoblast isolation from murine calvariae and long bones","author":"Bakker","year":"2003"},{"key":"10.1074\/jbc.M115.649608_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00223-008-9104-y","article-title":"Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro","volume":"82","author":"Idris","year":"2008","journal-title":"Calcif. Tissue Int"},{"key":"10.1074\/jbc.M115.649608_bib37","series-title":"Bone Research Protocols","first-page":"545","article-title":"Assessing bone formation using mouse calvarial organ cultures","volume":"Vol. 816","author":"Garret","year":"2012"},{"key":"10.1074\/jbc.M115.649608_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr. Rev"},{"key":"10.1074\/jbc.M115.649608_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1196\/annals.1346.014","article-title":"M-CSF, c-Fms, and signaling in osteoclasts and their precursors","volume":"1068","author":"Ross","year":"2006","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"10.1074\/jbc.M115.649608_bib40","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1111\/j.1476-5381.2011.01519.x","article-title":"Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro","volume":"165","author":"Whyte","year":"2012","journal-title":"Br. J. Pharmacol"},{"key":"10.1074\/jbc.M115.649608_bib41","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/endo.140.10.7037","article-title":"Breast cancer cells interact with osteoblasts to support osteoclast formation","volume":"140","author":"Thomas","year":"1999","journal-title":"Endocrinology"},{"key":"10.1074\/jbc.M115.649608_bib42","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.bone.2006.09.002","article-title":"Parathyroid hormone activates phosphoinositide 3-kinase-Akt-Bad cascade in osteoblast-like cells","volume":"40","author":"Yamamoto","year":"2007","journal-title":"Bone"},{"key":"10.1074\/jbc.M115.649608_bib43","first-page":"440","article-title":"The steady-state expression of connexin43 is maintained by the PI3K\/Akt in osteoblasts","volume":"382","author":"Bhattacharjee","year":"2009","journal-title":"BBRC"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820448653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820448653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M115.649608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:15:04Z","timestamp":1779448504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820448653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":43,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0021925820448653"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m115.649608","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M115.649608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}